Prevalence of Moderate to Severe Anxiety Symptoms among Patients with Myocardial Infarction: a Meta-Analysis

This study attempted to synthesize the evidence on the prevalence of moderate to severe anxiety symptoms among myocardial infarction (MI) patients to offer a reliable and accurate estimate on the number of MI patients suffering from moderate to severe anxiety symptoms. Comprehensive electronic searc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychiatric quarterly 2022-03, Vol.93 (1), p.161-180
Hauptverfasser: Lian, Yajun, Xiang, Jingsha, Wang, Xiaoyan, Kaminga, Atipatsa C., Chen, Wenhang, Lai, Zhiwei, Dai, Wenjie, Yang, Jianzhou
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 180
container_issue 1
container_start_page 161
container_title Psychiatric quarterly
container_volume 93
creator Lian, Yajun
Xiang, Jingsha
Wang, Xiaoyan
Kaminga, Atipatsa C.
Chen, Wenhang
Lai, Zhiwei
Dai, Wenjie
Yang, Jianzhou
description This study attempted to synthesize the evidence on the prevalence of moderate to severe anxiety symptoms among myocardial infarction (MI) patients to offer a reliable and accurate estimate on the number of MI patients suffering from moderate to severe anxiety symptoms. Comprehensive electronic searches (PubMed, Embase and Web of Science) were performed from their inception to February 2021. Between-study heterogeneity was analyzed using the Cochran’s Q test and I 2 statistic, and if it was high across the eligible studies, meta-regression and subgroup analyses were conducted to examine the source of heterogeneity. Publication bias and the robustness of the pooled results were also examined. A total of 18 eligible studies covering 8,532 MI patients were included, of which 3,443 were identified with moderate to severe anxiety symptoms. Between-study heterogeneity was high ( I 2 =98.8%) with the reported prevalence ranging from 9.6% to 69.17%, and the pooled prevalence was 38.08% (95% confidence interval: 28.82–47.81%) by a random-effects model. Meta-regression analyses indicated that publication year ( β  = −0.014) was significant moderators contributing 16.11% to the heterogeneity. Subgroup analyses indicated that studies using the anxiety subscale of Brief Symptom Inventory to assess anxiety were homogenous ( I 2 =0.0). Furthermore, the pooled prevalence of moderate to severe anxiety symptoms varied significantly by geographic region, instrument used to assess anxiety, methodological quality, sex, education level, a history of previous MI and hypercholesterolemia. Additionally, the results of Egger’s linear test ( t  = −0.630) and Begg’s rank test ( z  = −0.190) indicated no evidence of publication bias, and the sensitivity of the pooled results was low. Nearly two fifth of MI patients suffered from moderate to severe anxiety symptoms, which emphasizes the importance of early identification of anxiety symptoms after MI, as well as the need of implementing psychological interventions for those with elevated anxiety symptoms.
doi_str_mv 10.1007/s11126-021-09921-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2529943660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2648320739</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-4f6d8c77ae034d52cc503cfce92c56be411cdbc37c9ef96f5c8adb00442121b83</originalsourceid><addsrcrecordid>eNp9kUFP3DAQha0KVLa0f6AHZIlLLyljO3Hi3lYIKBIrkGjPluNMICixt7YXmn-PYWmROHCZOcz33ozmEfKVwXcGUB9FxhiXBXBWgFK5zh_IglW1KGQNaocsAIQoeM1hj3yK8Q6AMSn4R7InSmBCNGpBxquA92ZEZ5H6nq58h8EkpMnTa7zHgHTp_g6YZno9T-vkp0jN5N0NvTJpQJcifRjSLV3N3prQDWak5643wabBux_U0BUmUyydGec4xM9ktzdjxC8vfZ_8Pj35dfyzuLg8Oz9eXhRW1FUqyl52ja1rgyDKruLWViBsb1FxW8kWS8Zs12bWKuyV7CvbmK4FKEvOOGsbsU--bX3Xwf_ZYEx6GqLFcTQO_SZqXnGlSiElZPTwDXrnNyHfmylZNoJDLVSm-JaywccYsNfrMEwmzJqBfspCb7PQOQv9nIWes-jgxXrTTtj9l_x7fgbEFoh55G4wvO5-x_YRb5KVtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2648320739</pqid></control><display><type>article</type><title>Prevalence of Moderate to Severe Anxiety Symptoms among Patients with Myocardial Infarction: a Meta-Analysis</title><source>MEDLINE</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>SpringerLink Journals - AutoHoldings</source><creator>Lian, Yajun ; Xiang, Jingsha ; Wang, Xiaoyan ; Kaminga, Atipatsa C. ; Chen, Wenhang ; Lai, Zhiwei ; Dai, Wenjie ; Yang, Jianzhou</creator><creatorcontrib>Lian, Yajun ; Xiang, Jingsha ; Wang, Xiaoyan ; Kaminga, Atipatsa C. ; Chen, Wenhang ; Lai, Zhiwei ; Dai, Wenjie ; Yang, Jianzhou</creatorcontrib><description>This study attempted to synthesize the evidence on the prevalence of moderate to severe anxiety symptoms among myocardial infarction (MI) patients to offer a reliable and accurate estimate on the number of MI patients suffering from moderate to severe anxiety symptoms. Comprehensive electronic searches (PubMed, Embase and Web of Science) were performed from their inception to February 2021. Between-study heterogeneity was analyzed using the Cochran’s Q test and I 2 statistic, and if it was high across the eligible studies, meta-regression and subgroup analyses were conducted to examine the source of heterogeneity. Publication bias and the robustness of the pooled results were also examined. A total of 18 eligible studies covering 8,532 MI patients were included, of which 3,443 were identified with moderate to severe anxiety symptoms. Between-study heterogeneity was high ( I 2 =98.8%) with the reported prevalence ranging from 9.6% to 69.17%, and the pooled prevalence was 38.08% (95% confidence interval: 28.82–47.81%) by a random-effects model. Meta-regression analyses indicated that publication year ( β  = −0.014) was significant moderators contributing 16.11% to the heterogeneity. Subgroup analyses indicated that studies using the anxiety subscale of Brief Symptom Inventory to assess anxiety were homogenous ( I 2 =0.0). Furthermore, the pooled prevalence of moderate to severe anxiety symptoms varied significantly by geographic region, instrument used to assess anxiety, methodological quality, sex, education level, a history of previous MI and hypercholesterolemia. Additionally, the results of Egger’s linear test ( t  = −0.630) and Begg’s rank test ( z  = −0.190) indicated no evidence of publication bias, and the sensitivity of the pooled results was low. Nearly two fifth of MI patients suffered from moderate to severe anxiety symptoms, which emphasizes the importance of early identification of anxiety symptoms after MI, as well as the need of implementing psychological interventions for those with elevated anxiety symptoms.</description><identifier>ISSN: 0033-2720</identifier><identifier>EISSN: 1573-6709</identifier><identifier>DOI: 10.1007/s11126-021-09921-y</identifier><identifier>PMID: 34013389</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Anxiety ; Anxiety - epidemiology ; Anxiety Disorders ; Bias ; Heart attacks ; Heterogeneity ; Humans ; Hypercholesterolemia ; Medicine ; Medicine &amp; Public Health ; Meta-analysis ; Moderators ; Myocardial infarction ; Myocardial Infarction - epidemiology ; Prevalence ; Psychiatry ; Public Health ; Review Article ; Risk Assessment ; Robustness ; Severity ; Sociology</subject><ispartof>Psychiatric quarterly, 2022-03, Vol.93 (1), p.161-180</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-4f6d8c77ae034d52cc503cfce92c56be411cdbc37c9ef96f5c8adb00442121b83</citedby><cites>FETCH-LOGICAL-c375t-4f6d8c77ae034d52cc503cfce92c56be411cdbc37c9ef96f5c8adb00442121b83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11126-021-09921-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11126-021-09921-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,12827,27905,27906,30980,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34013389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lian, Yajun</creatorcontrib><creatorcontrib>Xiang, Jingsha</creatorcontrib><creatorcontrib>Wang, Xiaoyan</creatorcontrib><creatorcontrib>Kaminga, Atipatsa C.</creatorcontrib><creatorcontrib>Chen, Wenhang</creatorcontrib><creatorcontrib>Lai, Zhiwei</creatorcontrib><creatorcontrib>Dai, Wenjie</creatorcontrib><creatorcontrib>Yang, Jianzhou</creatorcontrib><title>Prevalence of Moderate to Severe Anxiety Symptoms among Patients with Myocardial Infarction: a Meta-Analysis</title><title>Psychiatric quarterly</title><addtitle>Psychiatr Q</addtitle><addtitle>Psychiatr Q</addtitle><description>This study attempted to synthesize the evidence on the prevalence of moderate to severe anxiety symptoms among myocardial infarction (MI) patients to offer a reliable and accurate estimate on the number of MI patients suffering from moderate to severe anxiety symptoms. Comprehensive electronic searches (PubMed, Embase and Web of Science) were performed from their inception to February 2021. Between-study heterogeneity was analyzed using the Cochran’s Q test and I 2 statistic, and if it was high across the eligible studies, meta-regression and subgroup analyses were conducted to examine the source of heterogeneity. Publication bias and the robustness of the pooled results were also examined. A total of 18 eligible studies covering 8,532 MI patients were included, of which 3,443 were identified with moderate to severe anxiety symptoms. Between-study heterogeneity was high ( I 2 =98.8%) with the reported prevalence ranging from 9.6% to 69.17%, and the pooled prevalence was 38.08% (95% confidence interval: 28.82–47.81%) by a random-effects model. Meta-regression analyses indicated that publication year ( β  = −0.014) was significant moderators contributing 16.11% to the heterogeneity. Subgroup analyses indicated that studies using the anxiety subscale of Brief Symptom Inventory to assess anxiety were homogenous ( I 2 =0.0). Furthermore, the pooled prevalence of moderate to severe anxiety symptoms varied significantly by geographic region, instrument used to assess anxiety, methodological quality, sex, education level, a history of previous MI and hypercholesterolemia. Additionally, the results of Egger’s linear test ( t  = −0.630) and Begg’s rank test ( z  = −0.190) indicated no evidence of publication bias, and the sensitivity of the pooled results was low. Nearly two fifth of MI patients suffered from moderate to severe anxiety symptoms, which emphasizes the importance of early identification of anxiety symptoms after MI, as well as the need of implementing psychological interventions for those with elevated anxiety symptoms.</description><subject>Anxiety</subject><subject>Anxiety - epidemiology</subject><subject>Anxiety Disorders</subject><subject>Bias</subject><subject>Heart attacks</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Hypercholesterolemia</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Meta-analysis</subject><subject>Moderators</subject><subject>Myocardial infarction</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Prevalence</subject><subject>Psychiatry</subject><subject>Public Health</subject><subject>Review Article</subject><subject>Risk Assessment</subject><subject>Robustness</subject><subject>Severity</subject><subject>Sociology</subject><issn>0033-2720</issn><issn>1573-6709</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kUFP3DAQha0KVLa0f6AHZIlLLyljO3Hi3lYIKBIrkGjPluNMICixt7YXmn-PYWmROHCZOcz33ozmEfKVwXcGUB9FxhiXBXBWgFK5zh_IglW1KGQNaocsAIQoeM1hj3yK8Q6AMSn4R7InSmBCNGpBxquA92ZEZ5H6nq58h8EkpMnTa7zHgHTp_g6YZno9T-vkp0jN5N0NvTJpQJcifRjSLV3N3prQDWak5643wabBux_U0BUmUyydGec4xM9ktzdjxC8vfZ_8Pj35dfyzuLg8Oz9eXhRW1FUqyl52ja1rgyDKruLWViBsb1FxW8kWS8Zs12bWKuyV7CvbmK4FKEvOOGsbsU--bX3Xwf_ZYEx6GqLFcTQO_SZqXnGlSiElZPTwDXrnNyHfmylZNoJDLVSm-JaywccYsNfrMEwmzJqBfspCb7PQOQv9nIWes-jgxXrTTtj9l_x7fgbEFoh55G4wvO5-x_YRb5KVtA</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Lian, Yajun</creator><creator>Xiang, Jingsha</creator><creator>Wang, Xiaoyan</creator><creator>Kaminga, Atipatsa C.</creator><creator>Chen, Wenhang</creator><creator>Lai, Zhiwei</creator><creator>Dai, Wenjie</creator><creator>Yang, Jianzhou</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20220301</creationdate><title>Prevalence of Moderate to Severe Anxiety Symptoms among Patients with Myocardial Infarction: a Meta-Analysis</title><author>Lian, Yajun ; Xiang, Jingsha ; Wang, Xiaoyan ; Kaminga, Atipatsa C. ; Chen, Wenhang ; Lai, Zhiwei ; Dai, Wenjie ; Yang, Jianzhou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-4f6d8c77ae034d52cc503cfce92c56be411cdbc37c9ef96f5c8adb00442121b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anxiety</topic><topic>Anxiety - epidemiology</topic><topic>Anxiety Disorders</topic><topic>Bias</topic><topic>Heart attacks</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Hypercholesterolemia</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Meta-analysis</topic><topic>Moderators</topic><topic>Myocardial infarction</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Prevalence</topic><topic>Psychiatry</topic><topic>Public Health</topic><topic>Review Article</topic><topic>Risk Assessment</topic><topic>Robustness</topic><topic>Severity</topic><topic>Sociology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lian, Yajun</creatorcontrib><creatorcontrib>Xiang, Jingsha</creatorcontrib><creatorcontrib>Wang, Xiaoyan</creatorcontrib><creatorcontrib>Kaminga, Atipatsa C.</creatorcontrib><creatorcontrib>Chen, Wenhang</creatorcontrib><creatorcontrib>Lai, Zhiwei</creatorcontrib><creatorcontrib>Dai, Wenjie</creatorcontrib><creatorcontrib>Yang, Jianzhou</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>Research Library</collection><collection>Sociology Database (ProQuest)</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatric quarterly</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lian, Yajun</au><au>Xiang, Jingsha</au><au>Wang, Xiaoyan</au><au>Kaminga, Atipatsa C.</au><au>Chen, Wenhang</au><au>Lai, Zhiwei</au><au>Dai, Wenjie</au><au>Yang, Jianzhou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Moderate to Severe Anxiety Symptoms among Patients with Myocardial Infarction: a Meta-Analysis</atitle><jtitle>Psychiatric quarterly</jtitle><stitle>Psychiatr Q</stitle><addtitle>Psychiatr Q</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>93</volume><issue>1</issue><spage>161</spage><epage>180</epage><pages>161-180</pages><issn>0033-2720</issn><eissn>1573-6709</eissn><abstract>This study attempted to synthesize the evidence on the prevalence of moderate to severe anxiety symptoms among myocardial infarction (MI) patients to offer a reliable and accurate estimate on the number of MI patients suffering from moderate to severe anxiety symptoms. Comprehensive electronic searches (PubMed, Embase and Web of Science) were performed from their inception to February 2021. Between-study heterogeneity was analyzed using the Cochran’s Q test and I 2 statistic, and if it was high across the eligible studies, meta-regression and subgroup analyses were conducted to examine the source of heterogeneity. Publication bias and the robustness of the pooled results were also examined. A total of 18 eligible studies covering 8,532 MI patients were included, of which 3,443 were identified with moderate to severe anxiety symptoms. Between-study heterogeneity was high ( I 2 =98.8%) with the reported prevalence ranging from 9.6% to 69.17%, and the pooled prevalence was 38.08% (95% confidence interval: 28.82–47.81%) by a random-effects model. Meta-regression analyses indicated that publication year ( β  = −0.014) was significant moderators contributing 16.11% to the heterogeneity. Subgroup analyses indicated that studies using the anxiety subscale of Brief Symptom Inventory to assess anxiety were homogenous ( I 2 =0.0). Furthermore, the pooled prevalence of moderate to severe anxiety symptoms varied significantly by geographic region, instrument used to assess anxiety, methodological quality, sex, education level, a history of previous MI and hypercholesterolemia. Additionally, the results of Egger’s linear test ( t  = −0.630) and Begg’s rank test ( z  = −0.190) indicated no evidence of publication bias, and the sensitivity of the pooled results was low. Nearly two fifth of MI patients suffered from moderate to severe anxiety symptoms, which emphasizes the importance of early identification of anxiety symptoms after MI, as well as the need of implementing psychological interventions for those with elevated anxiety symptoms.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>34013389</pmid><doi>10.1007/s11126-021-09921-y</doi><tpages>20</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0033-2720
ispartof Psychiatric quarterly, 2022-03, Vol.93 (1), p.161-180
issn 0033-2720
1573-6709
language eng
recordid cdi_proquest_miscellaneous_2529943660
source MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); SpringerLink Journals - AutoHoldings
subjects Anxiety
Anxiety - epidemiology
Anxiety Disorders
Bias
Heart attacks
Heterogeneity
Humans
Hypercholesterolemia
Medicine
Medicine & Public Health
Meta-analysis
Moderators
Myocardial infarction
Myocardial Infarction - epidemiology
Prevalence
Psychiatry
Public Health
Review Article
Risk Assessment
Robustness
Severity
Sociology
title Prevalence of Moderate to Severe Anxiety Symptoms among Patients with Myocardial Infarction: a Meta-Analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T21%3A32%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Moderate%20to%20Severe%20Anxiety%20Symptoms%20among%20Patients%20with%20Myocardial%20Infarction:%20a%20Meta-Analysis&rft.jtitle=Psychiatric%20quarterly&rft.au=Lian,%20Yajun&rft.date=2022-03-01&rft.volume=93&rft.issue=1&rft.spage=161&rft.epage=180&rft.pages=161-180&rft.issn=0033-2720&rft.eissn=1573-6709&rft_id=info:doi/10.1007/s11126-021-09921-y&rft_dat=%3Cproquest_cross%3E2648320739%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2648320739&rft_id=info:pmid/34013389&rfr_iscdi=true